Faruqi & Faruqi, LLP Announces Investigation Related to the Acquisition of Cardiac Science Corporation - CSCX

Date : 11/01/2010 @ 5:43PM
Source : Business Wire
Stock : Cardiac Science Corp (MM) (CSCX)
Quote : 2.32  0.0 (0.00%) @ 2:05AM
Cardiac Science Corp (MM) share price Chart

Faruqi & Faruqi, LLP Announces Investigation Related to the Acquisition of Cardiac Science Corporation - CSCX

Cardiac Science Corp (MM) (NASDAQ:CSCX)
Historical Stock Chart

5 Years : From Feb 2013 to Feb 2018

Click Here for more Cardiac Science Corp (MM) Charts.

Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Cardiac Science Corporation (“Cardiac Science” or the “Company”) (NASDAQ: CSCX) for potential breaches of fiduciary duties in connection with their conduct related to the sale of the Company to Opto Circuits Limited. The proposed transaction offers Cardiac Science shareholders to only receive $2.30 per share in cash. The transaction is structured as a tender offer which may obviate the need for a shareholder vote. According to Thomson/First Call, at least one financial analyst values Cardiac Science’ common stock at $6.00 per share.

Request more information now by clicking here: www.faruqilaw.com/cscx

Whether the Cardiac Science’s Board of Directors breached their fiduciary duties to Cardiac Science’s stockholders by failing to conduct an adequate and fair sales process to sell the Company prior to agreeing to this proposed transaction, whether the proposed transaction undervalues Cardiac Science’s shares and by how much this proposed transaction undervalues the Company to the detriment of Cardiac Science shareholders are the key focus of this investigation.

Faruqi & Faruqi, LLP is a national law firm which represents investors and individuals in class action litigation. The firm is focused on providing exemplary legal services in complex litigation in the areas of securities, shareholder, antitrust and consumer litigation, through all phases of litigation. The firm has an experienced trial team which has achieved significant victories on behalf of the firm’s clients.

If you own common stock in Cardiac Science and wish to obtain additional information, please visit us at www.faruqilaw.com/cscx or contact Juan E. Monteverde, Esq. either via e-mail at jmonteverde@faruqilaw.com or by telephone at (877) 247-4292 or (212) 983-9330.

Attorney Advertising. (C) 2010 Faruqi & Faruqi, LLP. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We are happy to discuss your particular case.

Latest CSCX Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:43 V:us D:20180226 01:49:07